Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124347212 | 12434721 | 2 | F | 20160425 | 20160629 | 20160603 | 20160706 | EXP | FR-AFSSAPS-AN20160560 | FR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-35072FF | BOEHRINGER INGELHEIM | 78.13 | YR | M | Y | 0.00000 | 20160706 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124347212 | 12434721 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 300 MG | Y | 22512 | 150 | MG | CAPSULE | BID | |||||
| 124347212 | 12434721 | 2 | C | VALSARTAN. | VALSARTAN | 1 | Oral | 80 MG | 0 | 80 | MG | QD | |||||||
| 124347212 | 12434721 | 3 | C | DIAMICRON | GLICLAZIDE | 1 | Oral | 60 MG | 0 | 60 | MG | PROLONGED-RELEASE TABLET | QD | ||||||
| 124347212 | 12434721 | 4 | C | METFORMINE | METFORMIN HYDROCHLORIDE | 1 | Unknown | 1000 MG | 0 | 1000 | MG | QD | |||||||
| 124347212 | 12434721 | 5 | C | ONGLYZA | SAXAGLIPTIN HYDROCHLORIDE | 1 | Oral | 0 | |||||||||||
| 124347212 | 12434721 | 6 | C | LASILIX | FUROSEMIDE | 1 | Oral | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124347212 | 12434721 | 1 | Atrial fibrillation |
| 124347212 | 12434721 | 2 | Product used for unknown indication |
| 124347212 | 12434721 | 3 | Product used for unknown indication |
| 124347212 | 12434721 | 4 | Product used for unknown indication |
| 124347212 | 12434721 | 5 | Product used for unknown indication |
| 124347212 | 12434721 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124347212 | 12434721 | DS |
| 124347212 | 12434721 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124347212 | 12434721 | Ischaemic stroke |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124347212 | 12434721 | 1 | 2013 | 0 | ||
| 124347212 | 12434721 | 5 | 201604 | 0 | ||
| 124347212 | 12434721 | 6 | 201604 | 0 |